The present invention provides uses of compounds that bind selectively to cells undergoing perturbations and alterations of their normal membrane organization, while binding to a lesser degree to cell having membranes of normal organization. These compounds are termed perturbed-membrane-binding compounds (PMBC). The PMBC group of compounds includes new compounds and also known compounds.

 
Web www.patentalert.com

< Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease

> Benzamidine derivatives

~ 00445